Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors

Acta Physiologica

Volumn 210, Issue 3, 2014, Pages 590-599

  Yang, J ^a   Zheng, X ^a   Haugen, F ^b   Dare E ^a   Lovdahl C ^a   Schulte, G ^a   Fredholm, B B ^a   Valen, G ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Adenosine; Adenosine receptor; Luciferase reporter; NF B; Smooth muscle cell

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA SMOOTH MUSCLE ACTIN; CAFFEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LUCIFERASE; NITROBENZYLTHIOINOSINE; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; ENZYME ACTIVITY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOSINE; ADENOSINE RECEPTOR; LUCIFERASE REPORTER; NFΚB; SMOOTH MUSCLE CELL;

ADENOSINE; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84893765040     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12176     Document Type: Article

References (41)

1. Amsterdam, A., Tajima, K. & Sasson, R. 2002. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64, 843-850.
2. Baldwin, S.A., Beal, P.R., Yao, S.Y., King, A.E., Cass, C.E. & Young, J.D. 2004. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447, 735-743.
3. Ballarin, M., Fredholm, B.B., Ambrosio, S. & Mahy, N. 1991. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 142, 97-103.
4. Bar-Yehuda, S., Stemmer, S.M., Madi, L., Castel, D., Ochaion, A., Cohen, S., Barer, F., Zabutti, A., Perez-Liz, G., Del Valle, L. & Fishman, P. 2008. The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol 33, 287-295.
5. Basheer, R., Rainnie, D.G., Porkka-Heiskanen, T., Ramesh, V. & McCarley, R.W. 2001. Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat. Neuroscience 104, 731-739.
6. Braun-Dullaeus, R.C., Mann, M.J. & Dzau, V.J. 1998. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 98, 82-89.
7. Carlsen, H., Moskaug, J.O., Fromm, S.H. & Blomhoff, R. 2002. In vivo imaging of NF-kappa B activity. J Immunol 168, 1441-1446.
8. Chunn, J.L., Young, H.W., Banerjee, S.K., Colasurdo, G.N. & Blackburn, M.R. 2001. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167, 4676-4685.
9. Combes, P. & Dickenson, J.M. 2001. Inhibition of NF-kappaB-mediated gene transcription by the human A2B adenosine receptor in Chinese hamster ovary cells. J Pharm Pharmacol 53, 1153-1156.
10. Decking, U.K., Schlieper, G., Kroll, K. & Schrader, J. 1997. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 81, 154-164.
11. Drury, A.N. & Szent-Gyorgyi, A. 1929. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68, 213-237.
12. Dux, E., Fastbom, J., Ungerstedt, U., Rudolphi, K. & Fredholm, B.B. 1990. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516, 248-256.
13. Fishman, P., Bar-Yehuda, S., Ardon, E., Rath-Wolfson, L., Barrer, F., Ochaion, A. & Madi, L. 2003. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 23, 2077-2083.
14. Fishman, P., Bar-Yehuda, S., Ohana, G., Barer, F., Ochaion, A., Erlanger, A. & Madi, L. 2004. An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. Oncogene 23, 2465-2471.
15. Fredholm, B.B. 2007. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14, 1315-1323.
16. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. & Linden, J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev, 53, 527-52.
17. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Linden, J. & Muller, C.E. 2011. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev, 63, 1-34.
18. Hagberg, H., Andersson, P., Lacarewicz, J., Jacobson, I., Butcher, S. & Sandberg, M. 1987. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem 49, 227-231.
19. Hasko, G. & Cronstein, B.N. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25, 33-39.
20. Jijon, H.B., Walker, J., Hoentjen, F., Diaz, H., Ewaschuk, J., Jobin, C. & Madsen, K.L. 2005. Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells. Cell Immunol 237, 86-95.
21. Karin, M. & Delhase, M. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12, 85-98.
22. Klotz, K.N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B.B. & Lohse, M.J. 1998. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357, 1-9.
23. Lee, H.S., Chung, H.J., Lee, H.W., Jeong, L.S. & Lee, S.K. 2011. Suppression of inflammation response by a novel A(3) adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-kappaB signaling. Immunobiology 216, 997-1003.
24. Lukashev, D., Ohta, A., Apasov, S., Chen, J.F. & Sitkovsky, M. 2004. Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173, 21-24.
25. Minguet, S., Huber, M., Rosenkranz, L., Schamel, W.W., Reth, M. & Brummer, T. 2005. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol 35, 31-41.
26. Morello, S., Sorrentino, R., Porta, A., Forte, G., Popolo, A., Petrella, A. & Pinto, A. 2009. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. J Cell Physiol 221, 378-386.
27. Ochaion, A., Bar-Yehuda, S., Cohen, S., Amital, H., Jacobson, K.A., Joshi, B.V., Gao, Z.G., Barer, F., Patoka, R., Del Valle, L., Perez-Liz, G. & Fishman, P. 2008. The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol 76, 482-494.
28. Ohta, A. & Sitkovsky, M. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920.
29. Persson, P.B. & Henriksson, J.J. 2011. Good publication practise in physiology. Acta Physiol 203, 403-407.
30. Pingle, S.C., Jajoo, S., Mukherjea, D., Sniderhan, L.F., Jhaveri, K.A., Marcuzzi, A., Rybak, L.P., Maggirwar, S.B. & Ramkumar, V. 2007. Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Mol Pharmacol 72, 856-867.
31. Ramesh, V., Thatte, H.S., McCarley, R.W. & Basheer, R. 2007. Adenosine and sleep deprivation promote NF-kappaB nuclear translocation in cholinergic basal forebrain. J Neurochem 100, 1351-1363.
32. Sands, W.A., Martin, A.F., Strong, E.W. & Palmer, T.M. 2004. Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transfer. Mol Pharmacol 66, 1147-1159.
33. Schrader, J., Schutz, W. & Bardenheuer, H. 1981. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J 196, 65-70.
34. Sun, Y., Duan, Y., Eisenstein, A.S., Hu, W., Quintana, A., Lam, W.K., Wang, Y., Wu, Z., Ravid, K. & Huang, P. 2012. A novel mechanism of control of NFkappaB activation and inflammation involving A2B adenosine receptors. J Cell Sci 125, 4507-4517.
35. Tomita, T., Takano, H., Tomita, N., Morishita, R., Kaneko, M., Shi, K., Takahi, K., Nakase, T., Kaneda, Y., Yoshikawa, H. & Ochi, T. 2000. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology (Oxford) 39, 749-757.
36. Valen, G., Yan, Z.Q. & Hansson, G.K. 2001. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38, 307-314.
37. Vincenzi, F., Targa, M., Corciulo, C., Gessi, S., Merighi, S., Setti, S., Cadossi, R., Borea, P.A. & Varani, K. 2012. The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells. PLoS ONE 7, e39317.
38. Williams, T.C. & Jarvis, S.M. 1991. Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. Biochem J 274(Pt 1), 27-33.
39. Yang, D., Zhang, Y., Nguyen, H.G., Koupenova, M., Chauhan, A.K., Makitalo, M., Jones, M.R., Hilaire, C.S., Seldin, D.C., Toselli, P., Larnperti, E., Schreiber, B.M., Gavras, H., Wagner, D.D. & Ravid, K. 2006. The A(2B) adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116, 1913-1923.
40. Yang, J.N., Tiselius, C., Dare, E., Johansson, B., Valen, G. & Fredholm, B.B. 2007. Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) 190, 63-75.
41. Ye, J.H. & Rajendran, V.M. 2009. Adenosine: an immune modulator of inflammatory bowel diseases. World J Gastroenterol 15, 4491-4498.